215 related articles for article (PubMed ID: 8184492)
21. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay.
Lutz WK; Kopp-Schneider A
Toxicol Sci; 1999 May; 49(1):110-5. PubMed ID: 10367348
[TBL] [Abstract][Full Text] [Related]
22. Use of short-term tests in determining the genotoxicity or nongenotoxicity of chemicals.
Ashby J
IARC Sci Publ; 1992; (116):135-64. PubMed ID: 1428079
[TBL] [Abstract][Full Text] [Related]
23. Kojic acid -absence of tumor-initiating activity in rat liver, and of carcinogenic and photo-genotoxic potential in mouse skin.
Higa Y; Kawabe M; Nabae K; Toda Y; Kitamoto S; Hara T; Tanaka N; Kariya K; Takahashi M
J Toxicol Sci; 2007 May; 32(2):143-59. PubMed ID: 17538239
[TBL] [Abstract][Full Text] [Related]
24. Absence of morphologic correlation between chemical toxicity and chemical carcinogenesis.
Huff J
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):45-53. PubMed ID: 8013424
[TBL] [Abstract][Full Text] [Related]
25. Overview of genotoxic carcinogens and non-genotoxic carcinogens.
Hayashi Y
Exp Toxicol Pathol; 1992 Dec; 44(8):465-71. PubMed ID: 1493365
[TBL] [Abstract][Full Text] [Related]
26. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
Bartsch H; Malaveille C
Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
Hernández LG; van Steeg H; Luijten M; van Benthem J
Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
[TBL] [Abstract][Full Text] [Related]
28. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
[TBL] [Abstract][Full Text] [Related]
29. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
30. Is current risk assessment of non-genotoxic carcinogens protective?
Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
[TBL] [Abstract][Full Text] [Related]
31. The unique role of rodents in the detection of possible human carcinogens and mutagens.
Ashby J
Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
[TBL] [Abstract][Full Text] [Related]
32. Can the concept of hormesis Be generalized to carcinogenesis?
Calabrese EJ; Baldwin LA
Regul Toxicol Pharmacol; 1998 Dec; 28(3):230-41. PubMed ID: 10049795
[TBL] [Abstract][Full Text] [Related]
33. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
34. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
Nioi P; Pardo ID; Sherratt PJ; Snyder RD
Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
[TBL] [Abstract][Full Text] [Related]
35. The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens.
Combes RD
Toxicol In Vitro; 2000 Aug; 14(4):387-99. PubMed ID: 10906445
[TBL] [Abstract][Full Text] [Related]
36. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
[TBL] [Abstract][Full Text] [Related]
37. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
38. DNA methylome alterations in chemical carcinogenesis.
Pogribny IP; Beland FA
Cancer Lett; 2013 Jun; 334(1):39-45. PubMed ID: 23010082
[TBL] [Abstract][Full Text] [Related]
39. Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscape.
Bevan RJ; Harrison PTC
Regul Toxicol Pharmacol; 2017 Aug; 88():291-302. PubMed ID: 28119000
[TBL] [Abstract][Full Text] [Related]
40. An Adverse Outcome Pathway Network for Chemically Induced Oxidative Stress Leading to (Non)genotoxic Carcinogenesis.
Veltman CHJ; Pennings JLA; van de Water B; Luijten M
Chem Res Toxicol; 2023 Jun; 36(6):805-817. PubMed ID: 37156502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
